A detailed history of Wells Fargo & Company transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 9,102 shares of THRD stock, worth $93,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,102
Previous 8,711 4.49%
Holding current value
$93,932
Previous $113,000 8.85%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.86 - $15.0 $4,246 - $5,865
391 Added 4.49%
9,102 $123,000
Q2 2024

Aug 13, 2024

BUY
$8.74 - $15.54 $16,169 - $28,749
1,850 Added 26.96%
8,711 $113,000
Q1 2024

May 10, 2024

BUY
$8.6 - $11.24 $7,611 - $9,947
885 Added 14.81%
6,861 $64,000
Q4 2023

Feb 09, 2024

BUY
$5.97 - $11.47 $7,062 - $13,569
1,183 Added 24.68%
5,976 $65,000
Q3 2023

Nov 13, 2023

SELL
$4.92 - $7.09 $12,644 - $18,221
-2,570 Reduced 34.9%
4,793 $30,000
Q2 2023

Aug 15, 2023

BUY
$4.18 - $5.33 $21,075 - $26,873
5,042 Added 217.23%
7,363 $35,000
Q1 2023

May 12, 2023

BUY
$3.95 - $4.49 $9,167 - $10,421
2,321 New
2,321 $9,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $416M
More about THRD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.